{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:52:04Z","timestamp":1788403924207,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02612-y","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T02:02:42Z","timestamp":1670983362000},"page":"2161-2169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-994X","authenticated-orcid":false,"given":"Ceylan Uslu","family":"Dogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8028-2647","authenticated-orcid":false,"given":"Can","family":"Tuzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-3382","authenticated-orcid":false,"given":"Ibrahim Cagri","family":"Turker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-453X","authenticated-orcid":false,"given":"Abdurrahman Alpaslan","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-135X","authenticated-orcid":false,"given":"Damla","family":"Culha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-5868","authenticated-orcid":false,"given":"Semra","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"2612_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","volume":"15","author":"A Leonardi","year":"2015","unstructured":"Leonardi A, Castegnaro A, Valerio AL, Lazzarini D (2015) Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study. Curr Opin Allergy Clin Immunol 15:482\u2013488. https:\/\/doi.org\/10.1097\/ACI.0000000000000204","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2612_CR2","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.ophtha.2013.03.044","volume":"120","author":"KH Wan","year":"2013","unstructured":"Wan KH, Chen LJ, Rong SS, Pang CP, Young AL (2013) Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis. Ophthalmology 120:2197\u20132203. https:\/\/doi.org\/10.1016\/j.ophtha.2013.03.044","journal-title":"Ophthalmology"},{"key":"2612_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ACI.0b013e3283303e2e","volume":"9","author":"I Offiah","year":"2009","unstructured":"Offiah I, Calder VL (2009) Immune mechanisms in allergic eye diseases: what is new? Curr Opin Allergy Clin Immunol 9:477\u2013481. https:\/\/doi.org\/10.1097\/ACI.0b013e3283303e2e","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2612_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.anai.2010.03.006","volume":"104","author":"A Stillerman","year":"2010","unstructured":"Stillerman A, Nachtsheim C, Li W, Albrecht M, Waldman J (2010) Efficacy of a novel air filtration pillow for avoidance of perennial allergens in symptomatic adults. Ann Allergy Asthma Immunol 104:440\u2013449. https:\/\/doi.org\/10.1016\/j.anai.2010.03.006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2612_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/ACI.0000000000000845","volume":"22","author":"L Bielory","year":"2022","unstructured":"Bielory L (2022) Immunobiologicals and ocular surface disease. Curr Opin Allergy Clin Immunol 22:314\u2013318. https:\/\/doi.org\/10.1097\/ACI.0000000000000845","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"2612_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/ACI.0000000000000843","volume":"22","author":"JP Kalangara","year":"2022","unstructured":"Kalangara JP, Vanijcharoenkarn K, Chisolm S, Kuruvilla ME (2022) Neuropathic pain and itch: mechanisms in allergic conjunctivitis. Curr Opin Allergy Clin Immunol 22(5):298\u2013303. https:\/\/doi.org\/10.1097\/ACI.0000000000000843","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2612_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1999.tb01167.x","author":"A Leonardi","year":"1999","unstructured":"Leonardi A (1999) Pathophysiology of allergic conjunctivitis. Acta Ophthalmol Scand Suppl. https:\/\/doi.org\/10.1111\/j.1600-0420.1999.tb01167.x","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"2612_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1442-9071.2006.01221.x","volume":"34","author":"A Fukushima","year":"2006","unstructured":"Fukushima A, Yamaguchi T, Ishida W, Fukata K, Liu FT, Ueno H (2006) Cyclosporin a inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions. Clin Exp Ophthalmol 34:347\u2013353. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01221.x","journal-title":"Clin Exp Ophthalmol"},{"key":"2612_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2018.03.008","volume":"67","author":"H Nolte","year":"2018","unstructured":"Nolte H, Maloney J (2018) The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases. Allergol Int 67:301\u2013308. https:\/\/doi.org\/10.1016\/j.alit.2018.03.008","journal-title":"Allergol Int"},{"key":"2612_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2500\/aap.2022.43.220026","volume":"43","author":"M Penagos","year":"2022","unstructured":"Penagos M, Durham SR (2022) Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy. Allergy Asthma Proc 43:292\u2013298. https:\/\/doi.org\/10.2500\/aap.2022.43.220026","journal-title":"Allergy Asthma Proc"},{"key":"2612_CR11","first-page":"689","volume":"70","author":"JL Huggins","year":"2004","unstructured":"Huggins JL, Looney RJ (2004) Allergen immunotherapy. Am Fam Physician 70:689\u2013696","journal-title":"Am Fam Physician"},{"key":"2612_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1034\/j.1398-9995.2002.1o3264.x","volume":"57","author":"PA Eng","year":"2002","unstructured":"Eng PA, Reinhold M, Gnehm HP (2002) Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 57:306\u2013312. https:\/\/doi.org\/10.1034\/j.1398-9995.2002.1o3264.x","journal-title":"Allergy"},{"key":"2612_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2045-7022-3-16","volume":"3","author":"J Rieker-Schwienbacher","year":"2013","unstructured":"Rieker-Schwienbacher J, Nell MJ, Diamant Z, van Ree R, Distler A, Boot JD et al (2013) Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. Clin Transl Allergy 3:16. https:\/\/doi.org\/10.1186\/2045-7022-3-16","journal-title":"Clin Transl Allergy"},{"key":"2612_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/all.13317","volume":"73","author":"G Roberts","year":"2018","unstructured":"Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R et al (2018) EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy 73:765\u2013798. https:\/\/doi.org\/10.1111\/all.13317","journal-title":"Allergy"},{"key":"2612_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00417-007-0697-z","volume":"246","author":"E Uchio","year":"2008","unstructured":"Uchio E, Kimura R, Migita H, Kozawa M, Kadonosono K (2008) Demographic aspects of allergic ocular diseases and evaluation of new criteria for clinical assessment of ocular allergy. Graefes Arch Clin Exp Ophthalmol 246:291\u2013296. https:\/\/doi.org\/10.1007\/s00417-007-0697-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2612_CR16","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.4103\/ijo.IJO_2112_18","volume":"67","author":"L Dudeja","year":"2019","unstructured":"Dudeja L, Janakiraman A, Dudeja I, Sane K, Babu M (2019) Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis. Indian J Ophthalmol 67:1400\u20131404. https:\/\/doi.org\/10.4103\/ijo.IJO_2112_18","journal-title":"Indian J Ophthalmol"},{"key":"2612_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaci.2021.03.026","volume":"148","author":"I Roumeau","year":"2021","unstructured":"Roumeau I, Coutu A, Navel V, Pereira B, Baker JS, Chiambaretta F et al (2021) Efficacy of medical treatments for vernal keratoconjunctivitis: a systematic review and meta-analysis. J Allergy Clin Immunol 148:822\u2013834. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.026","journal-title":"J Allergy Clin Immunol"},{"key":"2612_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ophtha.2018.12.027","volume":"126","author":"A Leonardi","year":"2019","unstructured":"Leonardi A, Doan S, Amrane M, Ismail D, Montero J, Nemeth J et al (2019) A randomized, controlled trial of cyclosporine a cationic emulsion in pediatric vernal keratoconjunctivitis: the vektis study. Ophthalmology 126:671\u2013681. https:\/\/doi.org\/10.1016\/j.ophtha.2018.12.027","journal-title":"Ophthalmology"},{"key":"2612_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.18502\/jovr.v14i4.5439","volume":"14","author":"A Chatterjee","year":"2019","unstructured":"Chatterjee A, Bandyopadhyay S, Kumar Bandyopadhyay S (2019) Efficacy, safety and steroid-sparing effect of topical cyclosporine a 0.05% for vernal keratoconjunctivitis in indian children. J Ophthalmic Vis Res 14:412\u2013418. https:\/\/doi.org\/10.18502\/jovr.v14i4.5439","journal-title":"J Ophthalmic Vis Res"},{"key":"2612_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.11622\/smedj.2015161.","volume":"57","author":"OE Yucel","year":"2016","unstructured":"Yucel OE, Ulus ND (2016) Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis. Singap Med J 57:507\u2013510. https:\/\/doi.org\/10.11622\/smedj.2015161.","journal-title":"Singap Med J"},{"key":"2612_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/jop.2008.0103","volume":"25","author":"N Ebihara","year":"2009","unstructured":"Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J et al (2009) A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther 25:365\u2013372. https:\/\/doi.org\/10.1089\/jop.2008.0103","journal-title":"J Ocul Pharmacol Ther"},{"key":"2612_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2019.11.020","volume":"212","author":"D Bremond-Gignac","year":"2020","unstructured":"Bremond-Gignac D, Doan S, Amrane M, Ismail D, Montero J, Nemeth J et al (2020) Twelve-month results of cyclosporine a cationic emulsion in a randomized study in patients with pediatric vernal keratoconjunctivitis. Am J Ophthalmol 212:116\u2013126. https:\/\/doi.org\/10.1016\/j.ajo.2019.11.020","journal-title":"Am J Ophthalmol"},{"key":"2612_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3126\/nepjoph.v12i1.24489","volume":"12","author":"K Subedi","year":"2020","unstructured":"Subedi K, Sharma B, Shrestha S (2020) Efficacy of topical cyclosporine 0.05% the treatment of vernal keratoconjunctivitis. Nepal J Ophthalmol 12:39\u201347. https:\/\/doi.org\/10.3126\/nepjoph.v12i1.24489","journal-title":"Nepal J Ophthalmol"},{"key":"2612_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/02713683.2019.1600197","volume":"44","author":"J Shoji","year":"2019","unstructured":"Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E et al (2019) Topical tacrolimus for chronic allergic conjunctival disease with and without atopic dermatitis. Curr Eye Res 44:796\u2013805. https:\/\/doi.org\/10.1080\/02713683.2019.1600197","journal-title":"Curr Eye Res"},{"key":"2612_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3126\/nepjoph.v9i2.19257","volume":"9","author":"R Kumari","year":"2017","unstructured":"Kumari R, Saha BC, Sinha BP, Mohan N (2017) Tacrolimus versus cyclosporine- comparative evaluation as first line drug in vernal keratoconjuctivitis. Nepal J Ophthalmol 9:128\u2013135. https:\/\/doi.org\/10.3126\/nepjoph.v9i2.19257","journal-title":"Nepal J Ophthalmol"},{"key":"2612_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/pai.12360","volume":"26","author":"N Pucci","year":"2015","unstructured":"Pucci N, Caputo R, di Grande L, de Libero C, Mori F, Barni S et al (2015) Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: a randomized, comparative, double-blind, crossover study. Pediatr Allergy Immunol 26:256\u2013261. https:\/\/doi.org\/10.1111\/pai.12360","journal-title":"Pediatr Allergy Immunol"},{"key":"2612_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41433-020-1013-y","volume":"35","author":"PK Maharana","year":"2021","unstructured":"Maharana PK, Singhal D, Raj N, Sharma N, Titiyal JS (2021) Role of combined immunomodulator therapy in severe steroid intolerant vernal keratoconjunctivitis. Eye (Lond) 35:979\u2013987. https:\/\/doi.org\/10.1038\/s41433-020-1013-y","journal-title":"Eye (Lond)"},{"key":"2612_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/cxo.13129","volume":"104","author":"A Trivedi","year":"2021","unstructured":"Trivedi A, Katelaris C (2021) Presentation, diagnosis, and the role of subcutaneous and sublingual immunotherapy in the management of ocular allergy. Clin Exp Optom 104:334\u2013349. https:\/\/doi.org\/10.1111\/cxo.13129","journal-title":"Clin Exp Optom"},{"key":"2612_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1398-9995.2009.02189.x","volume":"65","author":"F Agostinis","year":"2010","unstructured":"Agostinis F, Forti S, Di Berardino F (2010) Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy 65:410\u2013411. https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02189.x","journal-title":"Allergy"},{"key":"2612_CR30","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00417-019-04389-w","volume":"257","author":"KM Sayed","year":"2019","unstructured":"Sayed KM, Kamel AG, Ali AH (2019) One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 257:1989\u20131996. https:\/\/doi.org\/10.1007\/s00417-019-04389-w","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2612_CR31","first-page":"224","volume":"48","author":"G Manzotti","year":"2016","unstructured":"Manzotti G, Riario-Sforza GG, Dimatteo M, Scolari C, Makri E, Incorvaia C (2016) Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment. Eur Ann Allergy Clin Immunol 48:224\u2013227","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"2612_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/1744666X.2016.1196137","volume":"12","author":"CH Lin","year":"2016","unstructured":"Lin CH, Alandijani S, Lockey RF (2016) Subcutaneous versus sublingual immunotherapy. Expert Rev Clin Immunol 12:801\u2013803. https:\/\/doi.org\/10.1080\/1744666X.2016.1196137","journal-title":"Expert Rev Clin Immunol"},{"key":"2612_CR33","doi-asserted-by":"publisher","first-page":"106039","DOI":"10.1016\/j.rmed.2020.106039","volume":"170","author":"M Borg","year":"2020","unstructured":"Borg M, Lokke A, Hilberg O (2020) Compliance in subcutaneous and sublingual allergen immunotherapy: a nationwide study. Respir Med 170:106039. https:\/\/doi.org\/10.1016\/j.rmed.2020.106039","journal-title":"Respir Med"},{"key":"2612_CR34","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1111\/all.14246","volume":"75","author":"D Di Bona","year":"2020","unstructured":"Di Bona D, Bilancia M, Albanesi M, Caiaffa MF, Macchia L (2020) Cost-effectiveness of grass pollen allergen immunotherapy in adults. Allergy 75:2319\u20132329. https:\/\/doi.org\/10.1111\/all.14246","journal-title":"Allergy"},{"key":"2612_CR35","first-page":"135","volume":"31","author":"M Tizro","year":"2019","unstructured":"Tizro M, Farid Hosseini R, Khoshkhui M, Fouladvand A, Mohammadi M, Sistani S et al (2019) Evaluation of sub cutaneousrush immunotherapy effectiveness in perennial allergic rhinitis after a year from treatment. Iran J Otorhinolaryngol 31:135\u2013139","journal-title":"Iran J Otorhinolaryngol"},{"key":"2612_CR36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.pcl.2014.03.009","volume":"61","author":"V Miraldi Utz","year":"2014","unstructured":"Miraldi Utz V, Kaufman AR (2014) Allergic eye disease. Pediatr Clin North Am 61:607\u2013620. https:\/\/doi.org\/10.1016\/j.pcl.2014.03.009","journal-title":"Pediatr Clin North Am"},{"key":"2612_CR37","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s40265-017-0834-x","volume":"77","author":"SM Hoy","year":"2017","unstructured":"Hoy SM (2017) Ciclosporin ophthalmic emulsion 0.1%: a review in severe dry eye disease. Drugs 77:1909\u20131916. https:\/\/doi.org\/10.1007\/s40265-017-0834-x","journal-title":"Drugs"},{"key":"2612_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2500\/aap.2022.43.210108","volume":"43","author":"J Greiwe","year":"2022","unstructured":"Greiwe J, Bernstein JA (2022) Accelerated\/rush allergen immunotherapy. Allergy Asthma Proc 43:344\u2013349. https:\/\/doi.org\/10.2500\/aap.2022.43.210108","journal-title":"Allergy Asthma Proc"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02612-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02612-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02612-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:24:49Z","timestamp":1744158289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02612-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2612"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02612-y","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. We have no financial disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This clinical study is adhered to the tenets of the Declaration of Helsinki and its later amendments and was approved by the Local Ethics Committee of Gaziosmanpa\u015fa Training and Research Hospital, \u0130stanbul, Turkey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants have provided consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}